0

0

0

0

0

0

0

0

0

videos | IST

India is a 'giver' not receiver of COVID-19 vaccine now: Bharat Biotech’s Suchitra Ella

Hyderabad-based pharmaceutical firm Bharat Biotech on Friday said India is a 'giver' not the receiver of the COVID-19 vaccine in the healthcare space post-COVID.

Hyderabad-based pharmaceutical firm Bharat Biotech on Friday said India is a 'giver' not the receiver of the COVID-19 vaccine in the healthcare space post-COVID.
In an interview to CNBC-TV18's Shereen Bhan, Suchitra Ella, the joint managing director, said, "The company is finishing phase I and phase II of Covaxin in about 1,000 volunteers across the country very successfully without any kind of serious adverse events and going to show that the safety was proven in humans and also the immunogenicity was proven again in the phase II trial.
"Bharat Biotech, the company behind Covaxin, said it has now taken phase-III trials on 26,000 volunteers across 25 hospitals in this country and hopefully, it will be able to share some good news in terms of how the vaccine is behaving in this large community-based trial," Ella said at the Switch Summit.
Watch this video for more.